GILEAD SCIENCES INC Insider Trading for January 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for January 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 70,000 | 1,147,650 | 90,000 | |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 99.62 | 11,679 | 1,163,419 | 119,302 | 131 K to 119.3 K (-8.92 %) |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 98.77 | 26,179 | 2,585,781 | 130,981 | 157.2 K to 131 K (-16.66 %) |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 97.81 | 32,142 | 3,143,883 | 157,160 | 189.3 K to 157.2 K (-16.98 %) |
| Jan 20 2015 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 70,000 | 1,147,650 | 189,302 | 119.3 K to 189.3 K (+58.67 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 717 | 29,082 | 17,523 | |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 283 | 7,638 | 23,981 | |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 100.88 | 1,000 | 100,881 | 34,308 | 35.3 K to 34.3 K (-2.83 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 283 | 7,638 | 35,308 | 35 K to 35.3 K (+0.81 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 717 | 29,082 | 35,025 | 34.3 K to 35 K (+2.09 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 5,000 | 95,425 | 64,375 | |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 100.89 | 5,000 | 504,450 | 113,694 | 118.7 K to 113.7 K (-4.21 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 5,000 | 95,425 | 118,694 | 113.7 K to 118.7 K (+4.40 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,000 | 40,560 | 18,240 | |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 95.05 | 1,000 | 95,050 | 34,308 | 35.3 K to 34.3 K (-2.83 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,000 | 40,560 | 35,308 | 34.3 K to 35.3 K (+2.91 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 19.09 | 5,000 | 95,425 | 69,375 | |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 95.99 | 201 | 19,294 | 113,694 | 113.9 K to 113.7 K (-0.18 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 95.06 | 1,799 | 171,017 | 113,895 | 115.7 K to 113.9 K (-1.55 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 96.01 | 700 | 67,209 | 115,694 | 116.4 K to 115.7 K (-0.60 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 95.04 | 4,300 | 408,673 | 116,394 | 120.7 K to 116.4 K (-3.56 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 19.09 | 5,000 | 95,425 | 120,694 | 115.7 K to 120.7 K (+4.32 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 14.50 | 150,000 | 2,175,375 | 1,650,000 | |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 96.65 | 100 | 9,665 | 4,122,987 | 4.1 M to 4.1 M (0.00 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 95.92 | 17,700 | 1,697,731 | 4,123,087 | 4.1 M to 4.1 M (-0.43 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 95.01 | 132,200 | 12,559,992 | 4,140,787 | 4.3 M to 4.1 M (-3.09 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 14.50 | 150,000 | 2,175,375 | 4,272,987 | 4.1 M to 4.3 M (+3.64 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 10,000 | |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 95.96 | 1,000 | 95,956 | 15,641 | 16.6 K to 15.6 K (-6.01 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 95.04 | 4,000 | 380,144 | 16,641 | 20.6 K to 16.6 K (-19.38 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |
| Jan 05 2015 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Gift | G | 0.00 | 1,000 | 0 | 115,694 | 116.7 K to 115.7 K (-0.86 %) |